A carregar...
The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice
BACKGROUND: A defect in gallbladder contraction function plays a key role in the pathogenesis of gallstones. The cholecystokinin-1 receptor (CCK-1R) antagonists have been extensively investigated for their therapeutic effects on gastrointestinal and metabolic diseases in animal studies and clinical...
Na minha lista:
| Publicado no: | Eur J Clin Invest |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6037422/ https://ncbi.nlm.nih.gov/pubmed/26683129 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/eci.12580 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|